population health

Research in Review

Tool Helps Reduce Patient Stress Surrounding Prostate Cancer Care

07/22/2016

JCP Editors

A new tool may help make decisions less emotional for patients with low-risk prostate cancer and encourage patient-physician communication, according to results published in the Journal of Cancer Education. While...

A new...

07/22/2016

Journal of Clinical Pathways

Research in Review

Adjuvant Chemotherapy Improves Colon Cancer Outcomes

07/22/2016

JCP Editors

Adjuvant chemotherapy may improve survival in patients with stage II colon cancer regardless of treatment regimen, patient age, or high-risk pathologic features, according to a study published in the journal Cancer....

...

07/22/2016

Journal of Clinical Pathways

Research in Review

Aromatase Inhibitor-Treated Patients With Breast Cancer Lacking Necessary Testing

07/19/2016

JCP Editors

Older women most at risk for bone fractures may not be receiving recommended bone density assessments prior to receiving aromatase inhibitor (AI) treatment for breast cancer, according to a study published in the...

Older...

07/19/2016

Journal of Clinical Pathways

Research in Review

Anthracycline-based Regimens Improve Survival in Elderly Patients With Lymphoma

07/13/2016

JCP Editors

Findings from a single-center analysis have shown that anthracycline-based therapies may produce better outcomes in patients age 80 years and older with diffuse large B-cell lymphoma (DLBCL), supporting data reported...

...

07/13/2016

Journal of Clinical Pathways

Research in Review

Inherited Genes Highly Prevalent in Metastatic Prostate Cancer

07/12/2016

JCP Editors

Findings from a study recently published in the New England Journal of Medicine suggest that men with advanced prostate cancer may want to consider being tested for inherited gene mutations in order to help guide...

...

07/12/2016

Journal of Clinical Pathways

Research in Review

Myeloma Treatment Patterns Vary Among European Practices

07/11/2016

JCP Editors

  There is significant variation in how European practices treat patients with multiple myeloma, according to a cross-sectional study published in the British Journal of Haematology. For the study,...

...

07/11/2016

Journal of Clinical Pathways

Research in Review

Neoadjuvant Endocrine Therapy for Breast Cancer Produces Same Results as Combination Chemotherapy

07/08/2016

JCP Editors

Neoadjuvant endocrine therapy (NET) may be associated with similar response rates as neoadjuvant combination chemotherapy, but with significantly lower toxicity, findings from a study published in JAMA Oncology...

...

07/08/2016

Journal of Clinical Pathways

Research in Review

Financial Relationships in Clinical Guidelines Not Being Properly Disclosed

06/02/2016

JCP Editors

Financial relationships between organizations that produce clinical practice guidelines and biomedical companies are not being properly disclosed, according to findings from a recent report. When guidelines are...

...

06/02/2016

Journal of Clinical Pathways

Transplant Still Preferred Treatment Choice in Young Patients With Myeloma

05/31/2016

JCP Editors

Autologous stem cell transplantation (ASCT) is still the preferred treatment of choice for patients under the age of 65 years with newly diagnosed multiple myeloma (NDMM), according to early results from a phase 3...

...

05/31/2016

Journal of Clinical Pathways

Research in Review

Nutritional Status an Indicator of Survival in Patients With Esophageal Cancer

05/25/2016

JCP Editors

Nutritional status may be a prominent indicator of survival in elderly patients with esophageal cancer, claims a recently published study. Esophageal cancer is one of the leading causes of cancer-related death...

...

05/25/2016

Journal of Clinical Pathways